Status:
COMPLETED
Clobetasol Propionate Spray Versus Vehicle Spray for the Management of Moderate to Severe Plaque Psoriasis of the Scalp
Lead Sponsor:
Galderma R&D
Conditions:
Scalp Psoriasis
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The primary objective of this study is to evaluate the safety and efficacy of clobetasol propionate spray versus vehicle spray for the management of moderate to severe plaque psoriasis of the scalp.
Eligibility Criteria
Inclusion
- Subjects with diagnosis of moderate to severe plaque psoriasis of the scalp
Exclusion
- Subjects who need systemic treatment for their body psoriasis
- Subjects who have surface area involvement too large (\>20% Body Surface Area \[BSA\]) that would require more than 50 grams per week of study product
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
81 Patients enrolled
Trial Details
Trial ID
NCT00881868
Start Date
April 1 2009
End Date
December 1 2009
Last Update
August 25 2022
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Dermatology Research Associates
Los Angeles, California, United States, 90045
2
Hudson Dermatology
Evansville, Indiana, United States, 47714
3
Research Division of The Skin Specialty Group
New York, New York, United States, 10155
4
Dermatology Associates, PLLC
Seattle, Washington, United States, 98101